normethylfondaparinux

CHEBI:CHEBI_145599

Definition

A heparin pentasaccharide resulting from the hydrolysis of the O-methyl group of fondaparinux.

Chemical Information

Molecular Formula
C30H51N3O49S8
Molecular Mass
1494.190
Charge
0
SMILES
N(S(O)(=O)=O)[C@@H]1[C@@H](OS(O)(=O)=O)[C@H](O[C@@H]2O[C@@H]([C@@H](O[C@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3NS(O)(=O)=O)COS(O)(=O)=O)[C@H](O)[C@H]2O)C(O)=O)[C@H](O[C@@H]1O[C@H]4[C@H](O)[C@@H](OS(O)(=O)=O)[C@@H](O[C@H]4C(=O)O)O[C@H]5[C@H](O)[C@@H](NS(O)(=O)=O)[C@H](O[C@@H]5COS(O)(=O)=O)O)COS(O)(=O)=O
InChI
InChI=1S/C30H51N3O49S8/c34-10-4(1-69-86(54,55)56)73-27(8(11(10)35)32-84(48,49)50)77-19-13(37)14(38)29(79-22(19)24(40)41)76-17-6(3-71-88(60,61)62)74-28(9(33-85(51,52)53)18(17)81-89(63,64)65)78-20-15(39)21(82-90(66,67)68)30(80-23(20)25(42)43)75-16-5(2-70-87(57,58)59)72-26(44)7(12(16)36)31-83(45,46)47/h4-23,26-39,44H,1-3H2,(H,40,41)(H,42,43)(H,45,46,47)(H,48,49,50)(H,51,52,53)(H,54,55,56)(H,57,58,59)(H,60,61,62)(H,63,64,65)(H,66,67,68)/t4-,5-,6-,7-,8-,9-,10-,11-,12-,13-,14-,15+,16-,17-,18-,19+,20+,21-,22+,23-,26+,27-,28-,29-,30-/m1/s1
InChIKey
QORVASNHDCXGRB-VTDSAVNTSA-N

Alternative Names

  • GlcNS6S(a1-4)GlcA(b1-4)GlcNS3S6S(a1-4)IdoA2S(a1-4)a-GlcNS6S
  • WURCS=2.0/4,5,4/[a2122h-1a_1-5_2*NSO/3=O/3=O_6*OSO/3=O/3=O][a2121A-1a_1-5_2*OSO/3=O/3=O][a2122h-1a_1-5_2*NSO/3=O/3=O_3*OSO/3=O/3=O_6*OSO/3=O/3=O][a2122A-1b_1-5]/1-2-3-4-1/a4-b1_b4-c1_c4-d1_d4-e1
  • 2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1->4)-beta-D-glucopyranuronosyl-(1->4)-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1->4)-2-O-sulfo-alpha-L-idopyranuronosyl-(1->4)-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranose

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

core#notation
CHEBI:145599
oboInOwl#hasDbXref
GlyTouCan:G27775IZ

Additional References

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

chebi#has_functional_parent
http://purl.obolibrary.org/obo/CHEBI_61033
owl#annotatedSource
t112556
owl#someValuesFrom
t255934
oboInOwl#hasOBONamespace
chebi_ontology
oboInOwl#id
CHEBI:145599
core#notation
CHEBI:145599
oboInOwl#hasDbXref
GlyTouCan:G27775IZ
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_50249
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class